Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction.

MLA

Ribeuz, Hélène Le, et al. “Role of KCNK3 Dysfunction in Dasatinib-Associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction.” American Journal of Respiratory Cell and Molecular Biology, vol. 71, no. 1, July 2024, pp. 95–109. EBSCOhost, https://doi.org/10.1165/rcmb.2023-0185OC.

APA

Ribeuz, H. L., Willer, A. S.-M., Chevalier, B., Sancho, M., Masson, B., Eyries, M., Jung, V., Guerrera, I. C., Dutheil, M., Jekmek, K. E., Laubry, L., Carpentier, G., Perez-Vizcaino, F., Tu, L., Guignabert, C., Chaumais, M.-C., Péchoux, C., Humbert, M., Hinzpeter, A., … Antigny, F. (2024). Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction. American Journal of Respiratory Cell and Molecular Biology, 71(1), 95–109. https://doi.org/10.1165/rcmb.2023-0185OC

Chicago

Ribeuz, Hélène Le, Anaïs Saint-Martin Willer, Benoit Chevalier, Maria Sancho, Bastien Masson, Mélanie Eyries, Vincent Jung, et al. 2024. “Role of KCNK3 Dysfunction in Dasatinib-Associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction.” American Journal of Respiratory Cell and Molecular Biology 71 (1): 95–109. doi:10.1165/rcmb.2023-0185OC.